GR78094B - - Google Patents

Info

Publication number
GR78094B
GR78094B GR70603A GR830170603A GR78094B GR 78094 B GR78094 B GR 78094B GR 70603 A GR70603 A GR 70603A GR 830170603 A GR830170603 A GR 830170603A GR 78094 B GR78094 B GR 78094B
Authority
GR
Greece
Prior art keywords
hydrogen
considered
considered together
separately
considered separately
Prior art date
Application number
GR70603A
Other languages
English (en)
Inventor
F C Sciavolino
M A Guadliana
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of GR78094B publication Critical patent/GR78094B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
GR70603A 1982-03-01 1983-02-24 GR78094B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/353,547 US4382085A (en) 1982-03-01 1982-03-01 4"-Epi erythromycin A and derivatives thereof as useful antibacterial agents

Publications (1)

Publication Number Publication Date
GR78094B true GR78094B (el) 1984-09-26

Family

ID=23389603

Family Applications (1)

Application Number Title Priority Date Filing Date
GR70603A GR78094B (el) 1982-03-01 1983-02-24

Country Status (26)

Country Link
US (1) US4382085A (el)
EP (1) EP0087905B1 (el)
JP (1) JPS58159499A (el)
KR (1) KR850000965B1 (el)
AT (1) ATE15048T1 (el)
AU (1) AU555208B2 (el)
CA (1) CA1178596A (el)
CS (3) CS235036B2 (el)
DD (1) DD211565A5 (el)
DE (1) DE3360589D1 (el)
DK (1) DK157495C (el)
EG (1) EG16630A (el)
ES (2) ES520177A0 (el)
FI (1) FI74287C (el)
GR (1) GR78094B (el)
GT (1) GT198301599A (el)
HU (1) HU193157B (el)
IE (1) IE56056B1 (el)
IL (1) IL68004A (el)
NO (1) NO155932C (el)
NZ (1) NZ203417A (el)
PH (1) PH17908A (el)
PL (1) PL138758B1 (el)
PT (1) PT76298B (el)
RO (1) RO86647B (el)
ZA (1) ZA831356B (el)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526889A (en) * 1982-11-15 1985-07-02 Pfizer Inc. Epimeric azahomoerythromycin A derivative, intermediates and method of use
PH19293A (en) * 1982-11-15 1986-03-04 Pfizer Epimeric azahomoerythromycin,pharmaceutical composition containing the same and method of use thereof
ATE38519T1 (de) * 1983-09-06 1988-11-15 Pfizer Azahomoerythromycin-b-derivate und zwischenprodukte.
JPS60120895A (ja) * 1983-12-02 1985-06-28 Taisho Pharmaceut Co Ltd ６−０−メチル−２′−０，ν−ビス（ベンジルオキシカルボニル）−ν−デメチルエリスロマイシンａの製法
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法
EP0184921A3 (en) * 1984-12-08 1986-10-29 Beecham Group Plc Erythromycin derivatives
US4783811A (en) * 1984-12-27 1988-11-08 Texas Instruments Incorporated Method and apparatus for determining syllable boundaries
US4640910A (en) * 1985-11-12 1987-02-03 Abbott Laboratories Erythromycin A silylated compounds and method of use
US4681872A (en) * 1985-11-12 1987-07-21 Abbott Laboratories Erythromycin A 11,12-carbonate and method of use
US4833236A (en) * 1986-05-02 1989-05-23 Taisho Pharmaceutical Co., Ltd. Erythromycin derivatives
WO1994026758A1 (en) * 1993-05-19 1994-11-24 Pfizer Inc. Intermediate for azithromycin
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
AU2003273254B2 (en) * 2002-08-29 2008-10-30 Bristol-Myers Squibb Company Motilide compounds
WO2004101592A1 (ja) * 2003-05-19 2004-11-25 Taisho Pharmaceutical Co., Ltd. エリスロマイシンａ誘導体の製造方法
US7211568B2 (en) * 2003-12-18 2007-05-01 Kosan Biosciences Incorporated 9-Desoxoerythromycin compounds as prokinetic agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3417077A (en) * 1966-05-16 1968-12-17 Lilly Co Eli Erythromycin derivative and process for the preparation thereof
US3884904A (en) * 1973-06-21 1975-05-20 Abbott Lab 11-Substituted erythromycin B derivatives
US3884903A (en) * 1973-06-21 1975-05-20 Abbott Lab 4{41 -Deoxy-4{41 -oxoerythromycin B derivatives
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
SE445223B (sv) * 1977-02-04 1986-06-09 Pfizer Sett att framstella 4"-amino-erytomylin-a-derivat

Also Published As

Publication number Publication date
KR850000965B1 (ko) 1985-07-02
DD211565A5 (de) 1984-07-18
AU1189883A (en) 1983-09-08
NO155932B (no) 1987-03-16
DK96783A (da) 1983-09-02
PH17908A (en) 1985-01-25
AU555208B2 (en) 1986-09-18
JPH0140039B2 (el) 1989-08-24
DK96783D0 (da) 1983-02-28
CA1178596A (en) 1984-11-27
EP0087905B1 (en) 1985-08-21
DK157495B (da) 1990-01-15
RO86647B (ro) 1985-05-01
NZ203417A (en) 1985-10-11
RO86647A (ro) 1985-04-17
DE3360589D1 (en) 1985-09-26
FI830654A0 (fi) 1983-02-28
ZA831356B (en) 1983-11-30
IE830411L (en) 1983-09-01
IL68004A (en) 1986-11-30
CS235049B2 (en) 1985-04-16
PL240764A1 (en) 1985-01-02
EP0087905A1 (en) 1983-09-07
ES526323A0 (es) 1985-11-16
ATE15048T1 (de) 1985-09-15
EG16630A (en) 1991-03-30
DK157495C (da) 1990-06-11
FI74287B (fi) 1987-09-30
PT76298A (en) 1983-03-01
CS235036B2 (en) 1985-04-16
ES8403928A1 (es) 1984-04-01
FI830654L (fi) 1983-09-02
IL68004A0 (en) 1983-06-15
PL138758B1 (en) 1986-10-31
GT198301599A (es) 1984-09-13
JPS58159499A (ja) 1983-09-21
FI74287C (fi) 1988-01-11
IE56056B1 (en) 1991-04-10
ES8602837A1 (es) 1985-11-16
HU193157B (en) 1987-08-28
PT76298B (en) 1986-01-27
ES520177A0 (es) 1984-04-01
CS235048B2 (en) 1985-04-16
KR840003647A (ko) 1984-09-15
US4382085A (en) 1983-05-03
NO155932C (no) 1987-06-24
NO830686L (no) 1983-09-02

Similar Documents

Publication Publication Date Title
GR78094B (el)
AU591309B2 (en) Taxol derivatives, their preparation and pharmaceutical compositions containing them
AU583543B2 (en) New adamantanamine derivatives, processes for their preparation and drugs in which they are present
ES8404360A1 (es) Un procedimiento para preparar compuestos de cefem.
DE3461378D1 (en) Rifamycins derivatives and preparation and pharmaceutical compositions thereof
PT75385B (en) Process for the preparation of aminoglycosides derivatives and of compositions containing these derivatives
ZA794155B (en) New aminoglycosides derived from desoxystreptamine,and their salts,their preparation process,their application as medicaments and the pharmaceutical compounds containing them
DE3569538D1 (en) Novel antibiotics, process for their preparation and pharmaceutical compositions containing them
AU567498B2 (en) 5-phenyl-1h-2,3-dihydro-1,4-benzodiazepine derivatives.
HU901631D0 (en) Process for the preparation of thienyl-piperazine derivatives and pharmaceutical compositions containing them
AU7993982A (en) Tetra-peptide
ES8405030A1 (es) Un procedimiento para la preparacion de derivados de 3-amino-3-desmetoxifortimicina.